Sunshine Biopharma Replaces Bush & Associates With M&<a href="https://laohu8.com/S/TKKD.SI">K</a> CPAS as Independent Auditor; No Disagreements Reported
**Sunshine Biopharma Inc. Changes Independent Auditor** Sunshine Biopharma Inc. announced a change in its independent registered public accounting firm, effective September 24, 2025. The company dismissed Bush & Associates CPA LLC and appointed M&K CPAS, PLLC as its new auditor. The decision was approved unanimously by the board of directors and the audit committee. According to the company's filing, there were no disagreements with Bush & Associates regarding accounting principles, financial disclosures, or audit procedures during the most recent fiscal years or the interim period up to September 24, 2025. Furthermore, Bush & Associates' audit reports for the years ended December 31, 2023 and 2024 contained no adverse opinions or qualifications. Sunshine Biopharma indicated it has not yet received a response letter from Bush & Associates but will file it with the SEC upon receipt.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-007338), on September 30, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。